ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
ALPN
Delisted
ALPN was delisted on the 17th of May, 2024.
23 hedge funds and large institutions have $59.9M invested in Alpine Immune Sciences, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.83M |
| 2 |
O
OrbiMed
New York
|
+$2.55M |
| 3 |
FM
Frazier Management
Seattle,
Washington
|
+$2.55M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$94K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$71K |
Top Sellers
| 1 |
TM
Tiger Management
New York
|
-$172K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
-$129K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.9K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.7K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -405 | Closed |
|